522 related articles for article (PubMed ID: 1488123)
1. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
Su JH; Cummings BJ; Cotman CW
Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
3. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
[TBL] [Abstract][Full Text] [Related]
4. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
[TBL] [Abstract][Full Text] [Related]
5. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
Bame KJ; Danda J; Hassall A; Tumova S
J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
[TBL] [Abstract][Full Text] [Related]
6. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
[TBL] [Abstract][Full Text] [Related]
7. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
Snow AD; Nochlin D; Sekiguichi R; Carlson SS
Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
[TBL] [Abstract][Full Text] [Related]
8. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
Perlmutter LS; Chui HC; Saperia D; Athanikar J
Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
[TBL] [Abstract][Full Text] [Related]
9. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains.
van Horssen J; Wilhelmus MM; Heljasvaara R; Pihlajaniemi T; Wesseling P; de Waal RM; Verbeek MM
Brain Pathol; 2002 Oct; 12(4):456-62. PubMed ID: 12408231
[TBL] [Abstract][Full Text] [Related]
10. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
Buée L; Ding W; Delacourte A; Fillit H
Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
[TBL] [Abstract][Full Text] [Related]
11. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
12. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
[TBL] [Abstract][Full Text] [Related]
13. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease.
DeWitt DA; Silver J; Canning DR; Perry G
Exp Neurol; 1993 Jun; 121(2):149-52. PubMed ID: 8339766
[TBL] [Abstract][Full Text] [Related]
14. Association between vascular basement membrane components and the lesions of Alzheimer's disease.
Perlmutter LS; Barrón E; Saperia D; Chui HC
J Neurosci Res; 1991 Dec; 30(4):673-81. PubMed ID: 1787541
[TBL] [Abstract][Full Text] [Related]
15. Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease.
Cummings BJ; Su JH; Cotman CW
Exp Neurol; 1993 Dec; 124(2):315-25. PubMed ID: 8287930
[TBL] [Abstract][Full Text] [Related]
16. What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease.
Benditt EP
Neurobiol Aging; 1989; 10(5):506; discussion 510-2. PubMed ID: 2530463
[TBL] [Abstract][Full Text] [Related]
17. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O
J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
[TBL] [Abstract][Full Text] [Related]
18. Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein.
Schubert D; Schroeder R; LaCorbiere M; Saitoh T; Cole G
Science; 1988 Jul; 241(4862):223-6. PubMed ID: 2968652
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.
Van Gool D; David G; Lammens M; Baro F; Dom R
Dementia; 1993; 4(6):308-14. PubMed ID: 8136893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
